Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C175 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Wednesday 05/08/19
01:00 PM - 03:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders, learn to critically select therapies, and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EDT Introduction Introduction
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­
01:05 PM - 01:55 PM EDT Speaker Myasthenia Gravis: Diagnosis
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­
01:55 PM - 02:45 PM EDT Speaker Myasthenia Gravis: Management
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­
02:45 PM - 03:00 PM EDT Q&A Discussion
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­, Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­ Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.